Purinergic signaling in the organ of Corti: Potential therapeutic targets of sensorineural hearing losses

Eszter Berekméri, Judit Szepesy, L. Köles, T. Zelles

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Purinergic signaling is deeply involved in the development, functions and protective mechanisms of the cochlea. Release of ATP and activation of purinergic receptors on sensory and supporting/epithelial cells play a substantial role in cochlear (patho)physiology. Both the ionotropic P2X and the metabotropic P2Y receptors are widely distributed on the inner and outer hair cells as well as on the different supporting cells in the organ of Corti and on other epithelial cells in the scala media. Among others, they are implicated in the sensitivity adjustment of the receptor cells by a K + shunt and can attenuate the cochlear amplification by modifying cochlear micromechanics acting on outer hair cells and supporting cells. Cochlear blood flow is also regulated by purines. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy. Decreasing hearing sensitivity and increasing cochlear blood supply by pharmacological targeting of purinergic signaling in the cochlea are potential new therapeutic approaches in these hearing disabilities, especially in the noise-induced ones.

Original languageEnglish
JournalBrain Research Bulletin
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Organ of Corti
Sensorineural Hearing Loss
Cochlea
Outer Auditory Hair Cells
Inner Auditory Hair Cells
Therapeutics
Hearing
Epithelial Cells
Cochlear Duct
Social Adjustment
Purinergic Receptors
Purines
Noise
Adenosine Triphosphate
Pharmacology
Drug Therapy

Keywords

  • Hearing sensitivity
  • Noise induced hearing loss
  • Organ of Corti
  • Purinergic signaling
  • Sensorineural hearing losses
  • Supporting cells

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Purinergic signaling in the organ of Corti : Potential therapeutic targets of sensorineural hearing losses. / Berekméri, Eszter; Szepesy, Judit; Köles, L.; Zelles, T.

In: Brain Research Bulletin, 01.01.2019.

Research output: Contribution to journalReview article

@article{e3ac4c441c80496db06316e277b6aabc,
title = "Purinergic signaling in the organ of Corti: Potential therapeutic targets of sensorineural hearing losses",
abstract = "Purinergic signaling is deeply involved in the development, functions and protective mechanisms of the cochlea. Release of ATP and activation of purinergic receptors on sensory and supporting/epithelial cells play a substantial role in cochlear (patho)physiology. Both the ionotropic P2X and the metabotropic P2Y receptors are widely distributed on the inner and outer hair cells as well as on the different supporting cells in the organ of Corti and on other epithelial cells in the scala media. Among others, they are implicated in the sensitivity adjustment of the receptor cells by a K + shunt and can attenuate the cochlear amplification by modifying cochlear micromechanics acting on outer hair cells and supporting cells. Cochlear blood flow is also regulated by purines. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy. Decreasing hearing sensitivity and increasing cochlear blood supply by pharmacological targeting of purinergic signaling in the cochlea are potential new therapeutic approaches in these hearing disabilities, especially in the noise-induced ones.",
keywords = "Hearing sensitivity, Noise induced hearing loss, Organ of Corti, Purinergic signaling, Sensorineural hearing losses, Supporting cells",
author = "Eszter Berekm{\'e}ri and Judit Szepesy and L. K{\"o}les and T. Zelles",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.brainresbull.2019.01.029",
language = "English",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Purinergic signaling in the organ of Corti

T2 - Potential therapeutic targets of sensorineural hearing losses

AU - Berekméri, Eszter

AU - Szepesy, Judit

AU - Köles, L.

AU - Zelles, T.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purinergic signaling is deeply involved in the development, functions and protective mechanisms of the cochlea. Release of ATP and activation of purinergic receptors on sensory and supporting/epithelial cells play a substantial role in cochlear (patho)physiology. Both the ionotropic P2X and the metabotropic P2Y receptors are widely distributed on the inner and outer hair cells as well as on the different supporting cells in the organ of Corti and on other epithelial cells in the scala media. Among others, they are implicated in the sensitivity adjustment of the receptor cells by a K + shunt and can attenuate the cochlear amplification by modifying cochlear micromechanics acting on outer hair cells and supporting cells. Cochlear blood flow is also regulated by purines. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy. Decreasing hearing sensitivity and increasing cochlear blood supply by pharmacological targeting of purinergic signaling in the cochlea are potential new therapeutic approaches in these hearing disabilities, especially in the noise-induced ones.

AB - Purinergic signaling is deeply involved in the development, functions and protective mechanisms of the cochlea. Release of ATP and activation of purinergic receptors on sensory and supporting/epithelial cells play a substantial role in cochlear (patho)physiology. Both the ionotropic P2X and the metabotropic P2Y receptors are widely distributed on the inner and outer hair cells as well as on the different supporting cells in the organ of Corti and on other epithelial cells in the scala media. Among others, they are implicated in the sensitivity adjustment of the receptor cells by a K + shunt and can attenuate the cochlear amplification by modifying cochlear micromechanics acting on outer hair cells and supporting cells. Cochlear blood flow is also regulated by purines. Sensorineural hearing losses currently lack any specific or efficient pharmacotherapy. Decreasing hearing sensitivity and increasing cochlear blood supply by pharmacological targeting of purinergic signaling in the cochlea are potential new therapeutic approaches in these hearing disabilities, especially in the noise-induced ones.

KW - Hearing sensitivity

KW - Noise induced hearing loss

KW - Organ of Corti

KW - Purinergic signaling

KW - Sensorineural hearing losses

KW - Supporting cells

UR - http://www.scopus.com/inward/record.url?scp=85061634787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061634787&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2019.01.029

DO - 10.1016/j.brainresbull.2019.01.029

M3 - Review article

AN - SCOPUS:85061634787

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

ER -